People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| S4 Medical Corp. | — | Biotechnology | Series A | $12.0M | $49.6M | 2023 |
Anila Lingamneni at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anila Lingamneni on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roy Tanaka | 1 | 6 |
| V. Kadir Kadhiresan | 1 | 5 |
| Hirak Parikh | 1 | 3 |
| Bill Baumel | 1 | 3 |
| William Fuller | 1 | 2 |
| Emile Daoud | 1 | 1 |
| Emile Daod | 1 | 1 |
| Roy Kadir Tanaka | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.